Covered recipient · General Payments record
MAX A HESSE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$2,033.61
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $405.52 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $185.77 | 6 |
| Axsome Therapeutics, Inc. | $121.81 | 1 |
| Lilly USA, LLC | $25.21 | 1 |
| PFIZER INC. | $19.29 | 1 |
| Phathom Pharmaceuticals, Inc. | $19.05 | 1 |
| Neurocrine BioSciences, Inc. | $18.32 | 1 |
| Novo Nordisk AS | $16.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.73 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103913773 | CMS |
| ABBVIE INC. | $86.43 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103913775 | CMS |
| ABBVIE INC. | $19.85 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103913777 | CMS |
| ABBVIE INC. | $15.35 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103913779 | CMS |
| ABBVIE INC. | $14.82 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103913781 | CMS |
| ABBVIE INC. | $33.59 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103913783 | CMS |
| Axsome Therapeutics, Inc. | $121.81 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148303732 | CMS |
| Lilly USA, LLC | $25.21 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135196660 | CMS |
| Neurocrine Biosciences, Inc. | $18.32 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150864479 | CMS |
| Novo Nordisk Inc | $16.07 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096700034 | CMS |
| PFIZER INC. | $19.29 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131115972 | CMS |
| Phathom Pharmaceuticals, Inc. | $19.05 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151071954 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.